Enanta Pharm (ENTA) Lost Twice as Much as Expected in Q1

February 13, 2014 7:41 AM

Enanta Pharm (NASDAQ: ENTA) reported Q1 EPS of ($0.30), $0.15 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found